Ever noticed how half the analysts on an earnings call update their models when the CFO mentions "normalized working capital" while the rest just blindly write it down? That’s the difference between reading a spreadsheet and actually understanding a business.

A good business isn't automatically a good stock. Here are a few things to look out for:

• PAT can lie but Free Cash Flow doesn't. Watch what actually consumes the cash instead of just looking at the headline profit.

• ROCE is the real truth teller. A company earning 35% ROCE compounds wealth, while one earning 9% with debt slowly destroys it.

• Gross margins reveal pricing power. If margins hold during a demand downturn, you've found structural power.

(Quick disclaimer: I am not SEBI registered, so please do not take this as investment advice! This is purely for educational purposes.)

I've broken down the mental models serious fund managers use to read companies in my latest piece, bridging the gap between fundamental and technical analysis. Check out the link in the comments or tune into the podcast version!

https://open.substack.com/pub/spicapitalresearch/p/the-gap-between-a-good-business-and

Found this interesting? Follow Shubham Singh for more such insights.

👉 Join our Community Channel for FREE on WhatsApp:

https://whatsapp.com/channel/0029VbCUIyF3AzNIZAA6GX0K

👉 Check my deep dives on various topics on Substack

https://spicapitalresearch.substack.com/

👉 Also if you are on insta (of course you are), Follow me on Insta

https://instagram.com/spicapitalresearch

#Investing #StockMarket #Valuation #Finance #FundamentalAnalysis

Day 28/100
Ever wonder how the pills in your medicine cabinet actually get made? We usually just look at the logo on the bottle, but the foundational chemistry happens much earlier in the supply chain.

I've been analyzing Divi’s Laboratories, a massive operation in Vishakhapatnam that acts as the quiet backbone for 12 of the world's top 20 pharma innovators.

(Quick disclaimer: I am not a SEBI-registered advisor, so please don't take this as investment advice! I'm just sharing some fascinating business mechanics).

Here is what makes their model so resilient:
The Hidden Moat: Once an innovator builds a clinical trial around Divi's specific chemistry, switching suppliers can trigger massive regulatory delays and cost millions in forgone revenue.

Looking Beyond PE: Trailing PE misses the mark because custom synthesis revenue is milestone-based. Their ~20.45% ROCE is a much stronger signal of their capital quality.

Global Infrastructure: As global supply chains actively move to reduce their dependency on China, Divi's functions more like an irreplaceable infrastructure asset than a standard pharma stock.

Check out my full deep dive into the supply chain no one draws correctly to learn more!
https://open.substack.com/pub/spicapitalresearch/p/divilabs-the-infrastructure-that
Found this interesting?
Join our Community Channel for FREE on WhatsApp
https://whatsapp.com/channel/0029VbCUIyF3AZNIZAA6GXOK

Also if you are on insta (of course you are), Follow me on Insta.
https://instagram.com/spicapitalresearch

#Investing #PharmaSector #CDMO #BusinessStrategy #StockMarket #100DaysWithTVS

Day 27/100

India's manufacturing story has a massive blind spot. Did you know that after four years, less than 8% of the ₹1.91 lakh crore PLI incentives have actually been disbursed?

First, a quick disclaimer: I am not a SEBI registered advisor, so none of this is investment advice. But the data from the ground speaks volumes:

1. The Winners: Electronics and Telecom thrived because the incentive structures perfectly matched their rapid capex cycles and production realities.

2. The Misses: Specialty Steel and Textiles are struggling with deep structural and policy mismatches.

3. The Auto Irony: The Auto PLI requires massive upfront capital, essentially locking out true EV innovators and rewarding legacy incumbents.

We are now entering Phase Two, shifting from large scale assembly to a deep tech component ecosystem. That gap is exactly where the next decade of unpriced value lies.

Check out my full deep dive into the realities of these schemes and what they actually mean for the market!

https://spicapitalresearch.substack.com/p/the-pli-mirage-which-schemes-actually?r=5uwf28

Found this interesting? Share it in your study group[s]/ or on LinkedIn

👉 Join our Community Channel for FREE on whatsapp:

https://whatsapp.com/channel/0029VbCUIyF3AzNIZAA6GX0K

👉 Check my deep dives on various topics on Substack.

https://spicapitalresearch.substack.com/

👉 Also if you are on Insta (of course you are), Follow me on Instagram.

https://instagram.com/spicapitalresearch